(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are BIOSENIC, BPOST, and SEABIRD EXPLORAT.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| BIOSENIC (BIOS.BR) | 0.11 | 13.98% | 2023-09-25 12:06:29 |
| BPOST (BPOST.BR) | 5.13 | 13.5% | 2023-09-25 12:06:33 |
| SEABIRD EXPLORAT (SBX.OL) | 5.64 | 8.67% | 2023-09-25 12:43:21 |
| SAS AB (SASNO.OL) | 0.30 | 5.87% | 2023-09-25 12:43:09 |
| ACANTHE DEV. (ACAN.PA) | 0.43 | 4.9% | 2023-09-25 12:45:22 |
| TECHSTEP (TECH.OL) | 10.47 | 4.9% | 2023-09-25 12:44:20 |
| ABIONYX PHARMA (ABNX.PA) | 1.18 | 4.81% | 2023-09-25 12:45:16 |
| IEP INVEST (IEP.BR) | 5.65 | 4.63% | 2023-09-25 12:20:21 |
| AJAX (AJAX.AS) | 10.20 | 3.87% | 2023-09-25 12:00:18 |
| HYLORIS (HYL.BR) | 12.15 | 3.85% | 2023-09-25 12:20:13 |
The three biggest losers today are ADOCIA, SPORTING, and CRESCENT.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| ADOCIA (ADOC.PA) | 6.74 | -14.58% | 2023-09-25 12:45:36 |
| SPORTING (SCP.LS) | 0.87 | -11.73% | 2023-09-25 12:24:35 |
| CRESCENT (OPTI.BR) | 0.01 | -10.77% | 2023-09-25 12:06:55 |
| BEAULIEU-AV. CERT (BEAB.BR) | 4.08 | -8.93% | 2023-09-25 12:06:16 |
| NEL (NEL.OL) | 9.10 | -8.51% | 2023-09-25 12:41:37 |
| ATLANTIC SAPPHIRE (ASA.OL) | 1.58 | -8.04% | 2023-09-25 12:25:37 |
| MKB Nedsense (NEDSE.AS) | 0.10 | -7.14% | 2023-09-25 12:03:45 |
| CRAYON GROUP HOLD (CRAYN.OL) | 68.40 | -6.81% | 2023-09-25 12:26:29 |
| ATENOR (ATEB.BR) | 16.05 | -6.41% | 2023-09-25 12:06:05 |
| MOREFIELD GROUP (MORE.AS) | 0.31 | -5.45% | 2023-09-25 12:03:47 |
Winners today
1. BIOSENIC (BIOS.BR)
13.98% Price Change
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.
BEL 20 ended the session with BIOSENIC rising 13.98% to €0.11 on Monday while BEL 20 dropped 1.49% to €3,580.79.
Earnings Per Share
As for profitability, BIOSENIC has a trailing twelve months EPS of €-0.01.
Volume
Today’s last reported volume for BIOSENIC is 4842680 which is 433.73% above its average volume of 907315.
More news about BIOSENIC.
2. BPOST (BPOST.BR)
13.5% Price Change
bpost NV/SA, together with its subsidiaries, provides mail and parcel services to individuals, businesses, and public institutions in Belgium, rest of Europe, the United States, and internationally. It operates through Belgium, E-Logistics Eurasia, E-Logistics North America, and Corporate segments. The company offers collection, transport, sorting, and distribution of addressed and non-addressed mail, printed documents, newspapers, periodicals, and parcels, as well as banking and financial products, e-commerce logistics, express delivery, proximity and convenience, document management, and related services. It also provides transactional mails, advertising mails, press, domestic and international parcels, logistic solutions, and cross-border products, as well as value-added services. The company was incorporated in 1830 and is headquartered in Brussels, Belgium.
BEL 20 ended the session with BPOST rising 13.5% to €5.13 on Monday while BEL 20 slid 1.49% to €3,580.79.
Earnings Per Share
As for profitability, BPOST has a trailing twelve months EPS of €0.96.
PE Ratio
BPOST has a trailing twelve months price to earnings ratio of 5.34. Meaning, the purchaser of the share is investing €5.34 for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BPOST’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for BPOST is 864486 which is 300.15% above its average volume of 216038.
Volatility
BPOST’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.11%, a positive 0.11%, and a positive 1.25%.
BPOST’s highest amplitude of average volatility was 1.11% (last week), 1.25% (last month), and 1.25% (last quarter).
More news about BPOST.
3. SEABIRD EXPLORAT (SBX.OL)
8.67% Price Change
SeaBird Exploration Plc, together with its subsidiaries, provides marine 2D and 3D seismic data for the oil and gas industry in Europe, Africa, the Middle East, North and South America, and the Asia Pacific. It offers 2D seismic; and source vessels that provide conventional undershoot, 4D repeat survey, wide azimuth, push reverse, long-term charter and vessel management, in-house source modelling and environmental decay analysis, and spot charter services. The company was founded in 1996 and is based in Nicosia, Cyprus.
Oslo Børs Benchmark Index_GI ended the session with SEABIRD EXPLORAT jumping 8.67% to €5.64 on Monday while Oslo Børs Benchmark Index_GI dropped 1.24% to €1,283.59.
Earnings Per Share
As for profitability, SEABIRD EXPLORAT has a trailing twelve months EPS of kr0.43.
PE Ratio
SEABIRD EXPLORAT has a trailing twelve months price to earnings ratio of 13.12. Meaning, the purchaser of the share is investing kr13.12 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.65%.
Volatility
SEABIRD EXPLORAT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.06%, a positive 0.29%, and a positive 2.00%.
SEABIRD EXPLORAT’s highest amplitude of average volatility was 0.58% (last week), 1.60% (last month), and 2.00% (last quarter).
More news about SEABIRD EXPLORAT.
4. SAS AB (SASNO.OL)
5.87% Price Change
SAS AB (publ), together with its subsidiaries, provides passenger flight transportation services in the Nordic and international route network. The company also offers air cargo services, in-flight sales, ground handling, and technical maintenance services, as well as travel-related loyalty programs. It operates a fleet of 135 aircraft, including 12 long-haul aircraft, 95 short-haul aircraft, and 28 aircraft flown by regional production partners. The company was founded in 1946 and is headquartered in Stockholm, Sweden. On July 5, 2022, SAS AB (publ), along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Oslo Børs Benchmark Index_GI ended the session with SAS AB rising 5.87% to €0.30 on Monday while Oslo Børs Benchmark Index_GI dropped 1.24% to €1,283.59.
Earnings Per Share
As for profitability, SAS AB has a trailing twelve months EPS of kr-0.66.
Volatility
SAS AB’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.28%, a negative 0.93%, and a positive 1.49%.
SAS AB’s highest amplitude of average volatility was 1.28% (last week), 1.69% (last month), and 1.49% (last quarter).
More news about SAS AB.
5. ACANTHE DEV. (ACAN.PA)
4.9% Price Change
As of December 31, 2022, Acanthe Développement's real estate portfolio represents an area of 9,374 m². During the year, the group sold, for €9.2 million, lots held in a building located on the Left Bank in Paris. All of the Group's buildings have been subject to appraisals, mainly carried out by the firm VIF EXPERTISE on December 31, 2022. The overall appraised value of the property portfolio (investment properties and building occupied by the Group) amounts to €117.1 million, an increase, at constant scope, of €1.6 million (+1.4%) compared to 2021. This increase in value confirms the relevant investment policy of the Group in the Central Business District of Paris. The appraised value of the assets stands at €117.1 million.
CAC 40 ended the session with ACANTHE DEV. rising 4.9% to €0.43 on Monday while CAC 40 dropped 0.85% to €7,123.88.
Earnings Per Share
As for profitability, ACANTHE DEV. has a trailing twelve months EPS of €0.03.
PE Ratio
ACANTHE DEV. has a trailing twelve months price to earnings ratio of 14.27. Meaning, the purchaser of the share is investing €14.27 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.2%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 7%, now sitting on 3.73M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ACANTHE DEV.’s stock is considered to be overbought (>=80).
Volatility
ACANTHE DEV.’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.75%, a positive 0.97%, and a positive 2.93%.
ACANTHE DEV.’s highest amplitude of average volatility was 3.15% (last week), 4.50% (last month), and 2.93% (last quarter).
Moving Average
ACANTHE DEV.’s worth is way above its 50-day moving average of €0.36 and way above its 200-day moving average of €0.37.
More news about ACANTHE DEV..
6. TECHSTEP (TECH.OL)
4.9% Price Change
Techstep ASA operates as a mobile technology enabler in Norway, Sweden, Denmark, and Poland. It offers mobile hardware, service, support, and mobility consultancy services; software as a service, as well as mobile expense management modules; and financing and remarketing services. The company also provides enterprise mobility management services, including mobile security, system design, implementation, and mobile device management. In addition, it develops and provides enterprise mobility software and solutions for the customers in the transportation, logistics, and public safety sectors, as well as offers mobile device lifecycle management solutions. The company was founded in 2016 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with TECHSTEP jumping 4.9% to €10.47 on Monday while Oslo Børs Benchmark Index_GI dropped 1.24% to €1,283.59.
Earnings Per Share
As for profitability, TECHSTEP has a trailing twelve months EPS of kr-2.55.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.38%.
Yearly Top and Bottom Value
TECHSTEP’s stock is valued at kr10.47 at 22:40 EST, way below its 52-week high of kr24.40 and way above its 52-week low of kr1.59.
Moving Average
TECHSTEP’s value is way below its 50-day moving average of kr13.45 and way below its 200-day moving average of kr13.10.
More news about TECHSTEP.
7. ABIONYX PHARMA (ABNX.PA)
4.81% Price Change
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. It has a strategic partnership with GTP Biologics and VBI Therapeutics Group for the bioproduction of the bio-HDL in France. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.
CAC 40 ended the session with ABIONYX PHARMA jumping 4.81% to €1.18 on Monday while CAC 40 fell 0.85% to €7,123.88.
Earnings Per Share
As for profitability, ABIONYX PHARMA has a trailing twelve months EPS of €-0.15.
More news about ABIONYX PHARMA.
8. IEP INVEST (IEP.BR)
4.63% Price Change
Iep Invest, NV is an investment firm specializing in investments in and loans to real estate companies. The firm previously operated as manufacturing group. It was formerly known as Punch International nv and changed its name to Iep Invest, NV in May 2014. Iep Invest, NV was founded in 1982 and is based in Antwerp, Belgium.
BEL 20 ended the session with IEP INVEST jumping 4.63% to €5.65 on Monday while BEL 20 fell 1.49% to €3,580.79.
Earnings Per Share
As for profitability, IEP INVEST has a trailing twelve months EPS of €-0.22.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.52%.
Yearly Top and Bottom Value
IEP INVEST’s stock is valued at €5.65 at 22:40 EST, way below its 52-week high of €10.50 and way higher than its 52-week low of €4.84.
More news about IEP INVEST.
9. AJAX (AJAX.AS)
3.87% Price Change
AFC Ajax NV operates a football club primarily in the Netherlands. The company also operates a stadium and an youth academy. In addition, it sells mobile tickets online. The company was incorporated in 1998 and is based in Amsterdam, the Netherlands.
AEX-Index ended the session with AJAX rising 3.87% to €10.20 on Monday while AEX-Index dropped 0.47% to €726.64.
Earnings Per Share
As for profitability, AJAX has a trailing twelve months EPS of €2.69.
PE Ratio
AJAX has a trailing twelve months price to earnings ratio of 3.79. Meaning, the purchaser of the share is investing €3.79 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.77%.
Volatility
AJAX’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.53%, a negative 0.45%, and a positive 1.36%.
AJAX’s highest amplitude of average volatility was 3.73% (last week), 1.85% (last month), and 1.36% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AJAX’s stock is considered to be oversold (<=20).
More news about AJAX.
10. HYLORIS (HYL.BR)
3.85% Price Change
Hyloris Pharmaceuticals SA engages in the develop, manufacture, and deliver pharmaceutical products to address unmet medical needs in cardiovascular health and other major therapeutic areas. It offers cardiovascular products for atrial fibrillation, acute coronary syndrome, advanced heart failure, congestive heart failure, acute coronary syndrome, and coronary heart disease. The company provides Maxigesic IV, a combination of paracetamol and ibuprofen used for post-operative non-opioid pain management; Tranexamic acid RTU, an antifibrinolytic drug for the formation of blood clots; Miconazole/Domiphen Bromide, a topical synergistic combination treatment for Recurrent Vulvovaginal Candidiasis; AlenuraTM, a first-line drug treatment for acute pain in interstitial cystitis/bladder pain syndrome; and Plecoid Agent IV for the treatment of acute myeloid leukemia and small cell lung cancer. It also offers Atomoxetine, an oral liquid for the treatment of patients with attention deficit hyperactivity disorder; HY-029, a liquid formulation of an antiviral drug to treat viral infections; HY-083, a nasal spray for the treatment of idiopathic rhinitis; and HY-088, an oral liquid that treats hypophosphatemia. The company was incorporated in 2012 and is headquartered in Liège, Belgium.
BEL 20 ended the session with HYLORIS jumping 3.85% to €12.15 on Monday while BEL 20 slid 1.49% to €3,580.79.
Earnings Per Share
As for profitability, HYLORIS has a trailing twelve months EPS of €-0.5.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.8%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 3.08M for the twelve trailing months.
Moving Average
HYLORIS’s worth is above its 50-day moving average of €11.47 and under its 200-day moving average of €12.26.
More news about HYLORIS.
Losers Today
1. ADOCIA (ADOC.PA)
-14.58% Price Change
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
CAC 40 ended the session with ADOCIA dropping 14.58% to €6.74 on Monday, following the last session’s upward trend. CAC 40 dropped 0.85% to €7,123.88, after two successive sessions in a row of losses, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, ADOCIA has a trailing twelve months EPS of €-2.31.
Yearly Top and Bottom Value
ADOCIA’s stock is valued at €6.74 at 22:40 EST, higher than its 52-week high of €6.62.
Volatility
ADOCIA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.01%, a negative 2.68%, and a positive 7.56%.
ADOCIA’s highest amplitude of average volatility was 12.93% (last week), 8.54% (last month), and 7.56% (last quarter).
Volume
Today’s last reported volume for ADOCIA is 279997 which is 4.71% below its average volume of 293863.
More news about ADOCIA.
2. SPORTING (SCP.LS)
-11.73% Price Change
Sporting Clube de Portugal – Futebol, SAD operates sports clubs in Portugal. The company also engages in the sale of tickets for games; advertising and sponsorships activities; and provision of television rights. Sporting Clube de Portugal – Futebol, SAD was founded in 1907 and is headquartered in Lisbon, Portugal.
PSI ended the session with SPORTING falling 11.73% to €0.87 on Monday, after two sequential sessions in a row of losses. PSI dropped 0.79% to €6,119.62, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, SPORTING has a trailing twelve months EPS of €0.13.
PE Ratio
SPORTING has a trailing twelve months price to earnings ratio of 6.65. Meaning, the purchaser of the share is investing €6.65 for every euro of annual earnings.
More news about SPORTING.
3. CRESCENT (OPTI.BR)
-10.77% Price Change
Crescent NV provides IoT integration services in Belgium. The company offers IoT engineering network services. It also produces and develops energy-efficient lighting technology. In addition, the company is involved in cloud and infrastructure services. Crescent NV was founded in 2018 and is based in Leuven, Belgium.
BEL 20 ended the session with CRESCENT dropping 10.77% to €0.01 on Monday while BEL 20 fell 1.49% to €3,580.79.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CRESCENT’s stock is considered to be overbought (>=80).
More news about CRESCENT.
4. BEAULIEU-AV. CERT (BEAB.BR)
-8.93% Price Change
Immo-Beaulieu NV owns and operates real estate properties. The company is based in Brussels, Belgium. Immo-Beaulieu NV operates as a subsidiary of KBC Bank NV.
BEL 20 ended the session with BEAULIEU-AV. CERT falling 8.93% to €4.08 on Monday while BEL 20 slid 1.49% to €3,580.79.
Volume
Today’s last reported volume for BEAULIEU-AV. CERT is 34 which is 46.87% below its average volume of 64.
More news about BEAULIEU-AV. CERT.
5. NEL (NEL.OL)
-8.51% Price Change
Nel ASA, a hydrogen company, provides various solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. The company operates in two segments, Nel Hydrogen Fueling and Nel Hydrogen Electrolyser. The Nel Hydrogen Fueling segment produces H2Station hydrogen fueling stations that provide fuel cell electric vehicles with the fueling and long range as conventional fossil fuel vehicles, include cars, buses, trucks, and other applications. The Nel Hydrogen Electrolyser segment supplies hydrogen production equipment based on alkaline and proton exchange membrane water electrolysis technology. It serves industry, energy, and gas companies. The company was formerly known as DiaGenic ASA and changed its name to Nel ASA in October 2014. Nel ASA was founded in 1927 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with NEL dropping 8.51% to €9.10 on Monday while Oslo Børs Benchmark Index_GI fell 1.24% to €1,283.59.
Earnings Per Share
As for profitability, NEL has a trailing twelve months EPS of kr-0.92.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.44%.
Yearly Top and Bottom Value
NEL’s stock is valued at kr9.10 at 22:40 EST, under its 52-week low of kr9.43.
Volatility
NEL’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.13%, a negative 0.77%, and a positive 1.97%.
NEL’s highest amplitude of average volatility was 1.28% (last week), 1.81% (last month), and 1.97% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 41.2% and 80.4%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NEL’s stock is considered to be overbought (>=80).
More news about NEL.
6. ATLANTIC SAPPHIRE (ASA.OL)
-8.04% Price Change
Atlantic Sapphire ASA, together with its subsidiaries, engages in the land-based salmon farming business. It operates through two segments, Fish Farming (Denmark); and Fish Farming (US). The company is involved in the production and sale of salmon. It operates in the United States, Denmark, and internationally. The company was founded in 2010 and is headquartered in Vikebukt, Norway.
Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE sliding 8.04% to €1.58 on Monday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI fell 1.24% to €1,283.59, following the last session’s upward trend on what was an all-around down trend exchanging session today.
Earnings Per Share
As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-5.62.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.
Volume
Today’s last reported volume for ATLANTIC SAPPHIRE is 880642 which is 8.87% above its average volume of 808850.
More news about ATLANTIC SAPPHIRE.
7. MKB Nedsense (NEDSE.AS)
-7.14% Price Change
MKB Nedsense N.V. engages in the finance and lending of money to natural persons and legal entities. It also provides guarantees and/or other securities towards third parties for its obligations and/or for obligations for companies in the investment portfolio. The company was formerly known as Nedsense Enterprises N.V. MKB Nedsense N.V. was founded in 1999 and is based in Bussum, the Netherlands.
AEX-Index ended the session with MKB Nedsense dropping 7.14% to €0.10 on Monday while AEX-Index slid 0.47% to €726.64.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.03%.
Volume
Today’s last reported volume for MKB Nedsense is 802 which is 91.86% below its average volume of 9862.
Yearly Top and Bottom Value
MKB Nedsense’s stock is valued at €0.10 at 22:40 EST, way under its 52-week high of €0.15 and way higher than its 52-week low of €0.09.
Moving Average
MKB Nedsense’s value is below its 50-day moving average of €0.11 and way below its 200-day moving average of €0.12.
More news about MKB Nedsense.
8. CRAYON GROUP HOLD (CRAYN.OL)
-6.81% Price Change
Crayon Group Holding ASA, together with its subsidiaries, operates as an IT advisory company. It operates through Software & Cloud Direct, Software & Cloud Channel, Software & Cloud Economics, and Consulting segments. The company provides assess and migrate services, including cloud migration assessment, maturity assessment, cloud infrastructure advisory and migration, cloud POC, cloud tenant migration, cloud connectivity, modern workplace migration, and cloud identity; govern and optimize services comprising IT governance, license optimization, software and cloud economics, and SAM tool; operate and support services, such as modern workplace adoption, software and cloud advisory service desk, cloud managed services, and support program services; and data platform and AI solutions services. It also offers software and IT asset management services. The company has operations in the Nordics, Europe, the Asia-Pacific, the Middle East and Africa, and the United States. Crayon Group Holding ASA was incorporated in 2011 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with CRAYON GROUP HOLD sliding 6.81% to €68.40 on Monday, after three consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI dropped 1.24% to €1,283.59, following the last session’s upward trend on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, CRAYON GROUP HOLD has a trailing twelve months EPS of kr-0.73.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.15%.
Volume
Today’s last reported volume for CRAYON GROUP HOLD is 1205420 which is 292.88% above its average volume of 306814.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CRAYON GROUP HOLD’s stock is considered to be overbought (>=80).
Sales Growth
CRAYON GROUP HOLD’s sales growth is 33.6% for the current quarter and negative 55.6% for the next.
More news about CRAYON GROUP HOLD.
9. ATENOR (ATEB.BR)
-6.41% Price Change
Atenor SA, a real estate development company, invests in large-scale real estate projects in Belgium, Luxembourg, the Netherlands, France, Germany, Portugal, Poland, Hungary, the United Kingdom, and Romania. The company develops real estate projects, such as offices and residential buildings. Atenor SA was founded in 1910 and is headquartered in La Hulpe, Belgium.
BEL 20 ended the session with ATENOR falling 6.41% to €16.05 on Monday, following the last session’s downward trend. BEL 20 fell 1.49% to €3,580.79, after two successive sessions in a row of losses, on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, ATENOR has a trailing twelve months EPS of €-9.45.
Volume
Today’s last reported volume for ATENOR is 5216 which is 49.11% above its average volume of 3498.
More news about ATENOR.
10. MOREFIELD GROUP (MORE.AS)
-5.45% Price Change
Morefield Group N.V. through its subsidiary Kersten Groep BV, engages in the selecting, advising, supplying, and maintaining medical aids for physical disability peoples. The company manufactures orthoses, such as braces and splints. It serves to municipalities, care administration offices, health insurers, and care institutions/care organizations. The company was formerly known as HeadFirst Source Group N.V. and changed its name to Morefield Group N.V. in January 2019. Morefield Group N.V. was incorporated in 1983 and is headquartered in Willemstad, Curaçao.
AEX-Index ended the session with MOREFIELD GROUP dropping 5.45% to €0.31 on Monday while AEX-Index fell 0.47% to €726.64.
Earnings Per Share
As for profitability, MOREFIELD GROUP has a trailing twelve months EPS of €0.09.
PE Ratio
MOREFIELD GROUP has a trailing twelve months price to earnings ratio of 3.47. Meaning, the purchaser of the share is investing €3.47 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.06%.
Volatility
MOREFIELD GROUP’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.47%, a positive 0.45%, and a positive 5.12%.
MOREFIELD GROUP’s highest amplitude of average volatility was 4.92% (last week), 5.71% (last month), and 5.12% (last quarter).
Volume
Today’s last reported volume for MOREFIELD GROUP is 2565 which is 74.45% below its average volume of 10043.
More news about MOREFIELD GROUP.
Stay up to date with our winners and losers daily report
